http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102018011361-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc951c2268896a53cef8f89015c1a593 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C279-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4168 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_525e8191729350f369a19876102b84cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b5178a5b31aba3a1f8950fb87c83f1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c05e0b641c661b1982de8cf82f14144 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18a014ea8759bf463d6c2ab70444e0c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f16c798e16c417b295e3a0731aa0d6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3ea8e9f78133c58a278a858ab73f9ca |
| publicationDate | 2019-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102018011361-A2 |
| titleOfInvention | synthetic compounds derived from aminoguanidines with antimicrobial activity |
| abstract | these are derivative compounds synthesized from aminoguanidines, which showed individual antimicrobial activity. aminoguanidines have versatility, easy access and low cost of obtaining, within this context, their production becomes possible, in addition to the possibility of several structural modifications, allowing their action aimed at different pharmacological activities. the aminoguanidine derivatives used in antimicrobial activity were: lqm 105 ((e) -2- (3,4-dichlorobenzylidine) -n-ethylhydrazinacarboximidamide), lqm 142 ((e) -2- (2- (3,4-dichlorobenzylidine) hydrazinyl) -4,5-dihydro-1h-imidazole) and lqm 144 ((e) -2- (2- (3,4-dichlorobenzylidine) hydrazinyl) -1,4,5,6-tetrahydropyrimidine). all synthetic compounds showed antimicrobial activity against the strains staphylococcus aureus (atcc 25923), staphylococcus epidermidis (atcc 14990), pseudomonas aeruginosa (atcc 27853) and escherichia coli (atcc 14942), which can be used in the development of antimicrobial products. |
| priorityDate | 2018-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.